Dosage protocol · Growth Hormone & Performance
CJC-1295 NO DAC 5 mg
Typical daily range: 100–300 mcg once daily (gradual titration).
- Reconstitute: Add 3.0 mL bacteriostatic water → ~1.67 mg/mL concentration.
- Typical daily range: 100–300 mcg once daily (gradual titration).
- Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL ≈ 16.7 mcg on a U‑100 insulin syringe.
- Storage: Lyophilized: refrigerate at 2–8 °C (35.6–46.4 °F); after reconstitution, refrigerate and use within 1–2 weeks; for longer storage, freeze at ≤−20 °C (≤−4 °F).
BAC water3.0mL
Concentration1.67mg/mL
Reconstitution
CJC-1295 NO DAC dosage chart
CJC-1295 NO DAC dosage chart
| Week | Dose | Draw |
|---|---|---|
| Weeks 1–2 | 100 mcg | 6 units0.06 mL |
| Weeks 3–4 | 150 mcg | 9 units0.09 mL |
| Weeks 5–6 | 200 mcg | 12 units0.12 mL |
| Weeks 7–12 | 250–300 mcg | 15–18 units0.18 mL |
How much to draw
The Draw column shows exactly where to stop on a U-100 insulin syringe. Different vial size or dose? The calculator below recomputes it live.
Supplies needed
Supplies needed
Peptide vial
The lyophilized compound
Bacteriostatic water
For reconstitution
U-100 insulin syringes
One per injection
Alcohol swabs
Stopper + site each time
How it works
CJC-1295 No DAC, also called CJC-1295 without DAC, CJC-1295 free base, or Modified GRF (1-29), is a synthetic GHRH analog chemically distinct from CJC-1295 DAC because it lacks the Drug Affinity Complex modification.[2] FDA briefing documents list the free-base and DAC forms as separate active moieties within a family of related substances and warn that naming across this group has been inconsistent in submitted records.[2]
That is not cosmetic: reviewers found clinical references sometimes attributed to the wrong CJC-1295 form, meaning a study or online claim described simply as "CJC-1295" may not specify which version was actually used.[2]
Benefits & side effects
The human research most cited in CJC-1295 discussions used the DAC form: placebo-controlled trials in healthy adults showed sustained, dose-dependent increases in growth hormone and IGF-1, with pulsatile secretion persisting during weeks of continuous exposure.[5] An FDA review found only three human studies of any CJC-1295 form, all in healthy volunteers, and none in people with a diagnosed disease.[2]
Preclinical rat pituitary-cell work supports the general mechanism.[3] A terminated ClinicalTrials.gov study of CJC-1295 in HIV-associated visceral obesity did not specify which form was used.[10] No human outcome data specific to CJC-1295 No DAC were identified, so claims about weight, muscle, sleep, or aging effects remain unsupported extrapolations from the DAC evidence or mechanism alone.
Calculator
Plan your own dose
Reconstituting a different vial size or targeting a different dose? Run the numbers.
1
Reconstitution
mg
mL
Concentration—
Per unit (0.01 mL)—
Per 10 units (0.1 mL)—
2
Your dose
Doses per vial—
Vial lasts—
Draw to
— units
=
—